Skip to main content

Advertisement

Table 1 Clinical and epidemiological characteristics of HIV infected patients and healthy donors

From: DBP rs16846876 and rs12512631 polymorphisms are associated with progression to AIDS naïve HIV-infected patients: a retrospective study

  Controls vs. all HIV patients HIV groups of patients
Characteristics Control All HIV (*) p-value (a) LTNPs-group MPs-group RPs-group p-value(b)
No. 113 667   183 334 150  
Male 93 (82.3%) 540 (81.4%) 0.829 115 (64.2%) 283 (84.7%) 142 (94.7%) < 0.001
Age (years) 42.0 (37.0; 49.0) 41.3 (35.0; 48.4) 0.427 48.7 (46.0; 51.7) 38.2 (33.2; 45.3) 38.3 (33.0; 43.8) < 0.001
Age of HIV diagnosis 34.3 (29.0; 40.4) 39.8 (34.3; 43.7) 31.8 (27.0; 38.4) 34.0 (29.6; 38.1) < 0.001
Year of HIV diagnosis 2006 (1999; 2008) 1993 (1990; 1997) 2006 (2004; 2008) 2009 (2007; 2010) < 0.001
HIV acquired        
 IDU 166 (25.0%) 130 (72.6%) 29 (8.7%) 7 (4.7%) < 0.001
 Homosexual 359 (54.1%) 13 (7.3%) 220 (65.9%) 126 (84.0%)  
 Heterosexual 118 (17.8%) 27 (15.1%) 76 (22.8%) 15 (10.0%)  
 Others 20 (3.0%) 9 (5.0%) 9 (2.7%) 2 (1.3%)  
  1. Abbreviations: IDU Intravenous drug users, HIV Human immunodeficiency virus, LTNPs Long Term Non Progressors, MPs Moderate Progressors, RPs Rapid progressors.
  2. Statistics: P-values were calculated by Chi-square or Fisher’s exact test, Mann-Whitney and Kruskal-Wallis tests.
  3. (a)differences between control group and all HIV infected patients.
  4. (b)differences among HIV groups. Statistically significant differences are shown in bold.
  5. (*)Clinical and epidemiological data for three HIV-infected patients were not available.